Who
Rajesh Asarpota
Chief Financial Officer
Company insider
Files Form 4 as: Chief Financial Officer, Maravai LifeSciences Holdings; Director, Profusa; CFO, Nuvasive; Sr. VP., CFO and PAO, Questcor Pharmaceuticals.
In numbers
- Trades disclosed
- 21
- Buys
- 0
- Sells
- 0
- Bought
- $0
- Sold
- $0
- Companies
- 4
- Companies where not an officer
- 1
- First trade
- 17 Feb 2014
- Last trade
- 30 Sep 2026
- Last filed
- 1 Oct 2026
Companies traded
Activity over time
Not enough dated trades to draw.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 30 Sep 2026filed 1 Oct 2026 | MRVI Maravai LifeSciences HoldingsLife-science tools | SEC FORM 4 Code F | $42K5,465 at $7.65 | filing |
| 31 Aug 2026filed 1 Sep 2026 | MRVI Maravai LifeSciences HoldingsLife-science tools | SEC FORM 4 Code F | $42K5,465 at $7.68 | filing |
| 31 Aug 2026filed 1 Sep 2026 | MRVI Maravai LifeSciences HoldingsLife-science tools | SEC FORM 4 Code F | $42K5,465 at $7.68 | filing |
| 30 Jul 2026filed 3 Aug 2026 | MRVI Maravai LifeSciences HoldingsLife-science tools | SEC FORM 4 Code F | $36K5,465 at $6.59 | filing |
| 30 Jul 2026filed 3 Aug 2026 | MRVI Maravai LifeSciences HoldingsLife-science tools | SEC FORM 4 Code F | $36K5,465 at $6.59 | filing |
| 30 Jun 2026filed 1 Jul 2026 | MRVI Maravai LifeSciences HoldingsLife-science tools | SEC FORM 4 Code F | $419K65,584 at $6.39 | filing |
| 30 Jun 2026filed 1 Jul 2026 | MRVI Maravai LifeSciences HoldingsLife-science tools | SEC FORM 4 Code F | $419K65,584 at $6.39 | filing |
| 26 Jan 2026filed 28 Jan 2026 | PFSA Profusaoption or derivative · Medical Devices | SEC FORM 4 Code A | —221,794 at $0.00 | filing |
| 26 Jan 2026filed 28 Jan 2026 | PFSA Profusaoption or derivative · Medical Devices | SEC FORM 4 Code A | —52,866 at $0.00 | filing |
| 26 Jan 2026filed 28 Jan 2026 | PFSA Profusaoption or derivative · Medical Devices | SEC FORM 4 Code A | —221,794 at $0.00 | filing |
| 26 Jan 2026filed 28 Jan 2026 | PFSA Profusaoption or derivative · Medical Devices | SEC FORM 4 Code A | —52,866 at $0.00 | filing |
| 30 Jun 2025filed 30 Jun 2025 | MRVI Maravai LifeSciences Holdingsoption or derivative · Life-science tools | SEC FORM 4 Code A | —333,333 at $0.00 | filing |
| 30 Jun 2025filed 30 Jun 2025 | MRVI Maravai LifeSciences Holdingsoption or derivative · Life-science tools | SEC FORM 4 Code A | —750,000 at $0.00 | filing |
| 30 Jun 2025filed 30 Jun 2025 | MRVI Maravai LifeSciences HoldingsLife-science tools | SEC FORM 4 Code A | —500,000 | filing |
| 1 Mar 2019filed 5 Mar 2019 | Nuvasiveoption or derivative | SEC FORM 4 Code A | —12,398 at $0.00 | filing |
| 6 Feb 2019filed 7 Feb 2019 | Nuvasiveoption or derivative | SEC FORM 4 Code A | —11,277 at $0.00 | filing |
| 7 Feb 2018filed 7 Feb 2019 | Nuvasiveoption or derivative | SEC FORM 4 Code A | —11,242 at $0.00 | filing |
| 14 Aug 2014filed 18 Aug 2014 | Questcor Pharmaceuticals | SEC FORM 4 Code D | —20,000 | filing |
| 14 Aug 2014filed 18 Aug 2014 | Questcor Pharmaceuticals | SEC FORM 4 Code D | —4,000 | filing |
| 24 Feb 2014filed 26 Feb 2014 | Questcor Pharmaceuticals | SEC FORM 4 Code A | —4,000 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.
Sectors
No trade we could place in a sector.